Global News

Teva, Microchips Biotech partner on digital drug delivery technology

Monday, June 22, 2015 11:01 AM

Teva Pharmaceutical Industries and Microchips Biotech, a Lexington, Mass.-based provider of microchip-based implants, have entered into a partnership to explore innovative ways to apply Microchips Biotech’s implantable drug delivery device to Teva’s portfolio of products with the goal of enhancing clinical outcomes for patients on chronic drug therapies.

More... »


Eli Lilly partners with Dana-Farber Cancer Institute, Sarah Cannon Research Institute

Monday, June 22, 2015 10:38 AM

Eli Lilly has inked two separate deals, one with the Dana-Farber Cancer Institute to research new medicines under development to fight cancer, and the second with the Sarah Cannon Research Institute (SCRI) to co-develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor.

More... »


Sirion Biotech to open new office in Boston

Monday, June 22, 2015 10:30 AM

Sirion Biotech, a viral vector platform company creating viral vector solutions for industry and academic partners headquartered in Germany, has committed to opening a new office in the vicinity of Boston.

More... »

Allergan to acquire Kythera Biopharmaceuticals

Monday, June 22, 2015 10:15 AM

Allergan, a global pharmaceutical company, has agreed to acquire Kythera Biopharmaceuticals, a Westlake Village, Calif.-based biopharmaceutical company, in a cash and equity transaction valued at $75 per Kythera share, or approximately $2.1 billion, subject to the fulfillment of certain customary conditions.

More... »

BIA responds to Jim O’Neill’s review on antimicrobial resistance

Monday, June 22, 2015 09:54 AM

The U.K. Bioindustry Association (BIA) has submitted its initial response to Jim O’Neill’s review on antimicrobial resistance (AMR), focusing on his interim report Securing new drugs for future generations: The antibiotics pipeline, published in May. Steve Bates, CEO of the BIA, put forward the case that any new economic model should be based on an informed stewardship not restrictive stewardship approach.

More... »

Digital messaging as a means of accelerating recruitment

Monday, June 22, 2015 08:00 AM

Sourcing and retaining qualified subjects for clinical trials continues to be one of the biggest challenges researchers face. Nearly 80% of trials fail to meet enrollment timelines. What if we could accelerate recruitment and improve the trial experience through the application of simple and secure digital messaging? 

More... »

Biotechnology Industry Organization to become Biotechnology Innovation Organization

Friday, June 19, 2015 12:16 PM

Biotechnology Industry Organization will soon change its name to the Biotechnology Innovation Organization.

More... »

AMRI, PerkinElmer collaborate on Buffalo Medical Hub

Friday, June 19, 2015 12:14 PM

Global CRO Albany Molecular Research (AMRI) and CRO PerkinElmer are collaborating in connection with the opening of AMRI's drug discovery center as part of the new Buffalo Medical Innovation and Commercialization Hub (BMIC). Co-located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, the Hub will accelerate drug discovery and innovation, and ultimately support the creation of more than 250 high tech jobs.

More... »

Quintiles launches new predictive and advanced analytics capabilities

Friday, June 19, 2015 12:00 PM

Global CRO Quintiles has added advanced statistical monitoring and predictive analytics capabilities to its risk-based monitoring (RBM) solution. Predictive and Advanced Analytics combine Quintiles' experience in RBM with its therapeutic and statistical sciences heritage to enable study teams to identify the right signals and predict clinical trial site performance and potential patient safety issues.

More... »

AstraZeneca, Inserm collaborate on type 2 diabetes, chronic kidney disease

Friday, June 19, 2015 11:37 AM

AstraZeneca has announced a three-year research collaboration with the French National Institute of Health and Medical Research (Inserm) to investigate new therapeutic approaches to type 2 diabetes and chronic kidney disease (CKD). The aim of the collaboration is to advance understanding of the biological mechanisms that underpin these conditions and develop new treatments based on this knowledge.

More... »

`

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs